Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody.
about
Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.Preclinical Pharmacokinetics Evaluation of Anti-heparin-binding EGF-like Growth Factor (HB-EGF) Monoclonal Antibody Using Cynomolgus Monkeys via (89)Zr-immuno-PET Study and the Determination of Drug Concentrations in Serum and Cerebrospinal Fluid.Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.
P2860
Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Effect of antigen-dependent cl ...... (HB-EGF) monoclonal antibody.
@ast
Effect of antigen-dependent cl ...... (HB-EGF) monoclonal antibody.
@en
type
label
Effect of antigen-dependent cl ...... (HB-EGF) monoclonal antibody.
@ast
Effect of antigen-dependent cl ...... (HB-EGF) monoclonal antibody.
@en
prefLabel
Effect of antigen-dependent cl ...... (HB-EGF) monoclonal antibody.
@ast
Effect of antigen-dependent cl ...... (HB-EGF) monoclonal antibody.
@en
P2093
P2860
P356
P1476
Effect of antigen-dependent cl ...... (HB-EGF) monoclonal antibody.
@en
P2093
Junichi Enokizono
Noriyuki Kasai
Yukitaka Yoshikawa
P2860
P304
P356
10.4161/MABS.29792
P577
2014-11-01T00:00:00Z